Vexev Raises $6 Mn to Advance AI-Powered Vascular Imaging Technology in the U.S.

Cardiovascular disease is the leading cause of death worldwide, causing nearly 20 million deaths each year. At the same time, many healthcare providers face challenges in accessing high-quality vascular imaging because of a shortage of specialists and differences in how scans are performed.

Vexev’s VxWave combines robotics, artificial intelligence, and ultrasound technology to automate vascular scans. The system is initially being developed for upper-limb imaging, with dialysis patients as its first major use case. These patients often need regular monitoring of their blood vessels.

Vexev recently completed a multi-site clinical study with U.S. Renal Care, a major U.S. dialysis provider. The study tested how VxWave could work in regular dialysis clinics and provided early clinical evidence supporting the technology.

During the study, VxWave achieved a 94% scanning success rate when used by non-specialist clinical staff. The technology could help make vascular imaging more consistent and may reduce the time needed to identify problems and begin treatment.

"We believe high-quality vascular imaging should be available wherever patients receive care, not only when a specialist is available," said John Carroll, PhD, co-founder and CEO of Vexev. "We are starting with dialysis patients because the clinical need is clear, but our vision is much broader: to build an autonomous imaging platform that helps clinicians make faster, more consistent and more informed decisions across vascular disease."

"Having worked closely with Vexev for several years, I have seen the development of its impressive robot- and AI-based techniques for vascular imaging," said Anupam Agarwal, MD, Senior Vice President for Medicine and Dean of the Marnix E. Heersink School of Medicine at the University of Alabama at Birmingham, and past president of the American Society of Nephrology. "The company's initial focus on dialysis vascular access addresses an important challenge for patients and providers, and I believe this technology has the potential to bring meaningful innovation to dialysis patients with vascular access challenges."

Vexev is an Australian medical robotics company that develops advanced technology for vascular imaging. Its goal is to make high-quality medical scans easier to access, more consistent and available on a larger scale.

The company was founded by experts in vascular fluid dynamics and computer-based imaging. Its main product, VxWave, is being developed to scan blood vessels in the upper arm. The technology will initially focus on dialysis patients and is being prepared for commercialization in the U.S.

Read Also- I Squared Capital to Acquire Australian Media Company oOh!media for A$898 Million